Amylyx Pharmaceuticals, Inc. (AMLX)

Amylyx Pharmaceuticals Revenue

Amylyx Pharmaceuticals had revenue of $-1.27M in the twelve months ending March 31, 2025, down -100.32% year-over-year. In the year 2024, Amylyx Pharmaceuticals had annual revenue of $87.37M, down -77.06%.

• Revenue (ttm): $-1.27M
• Revenue Growth: -100.32%
• P/S Ratio: -583.76
• Revenue / Employee: n/a
• Employees: 123
• Market Cap: 743.44M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	87.37M	-293.42M	-77.06%
Dec 31, 2023	380.79M	358.56M	1,612.94%
Dec 31, 2022	22.23M	21.95M	7,700.00%
Dec 31, 2021	285.00K	-365.00K	-56.15%
Dec 31, 2020	650.00K	-776.00K	-54.42%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.